| Financial Year |
March 31 2023 |
| Monetary Funds |
2,828,330,456.01 |
| Held-for-trading Financial Assets |
153,319,966.91 |
| Notes Receivable |
971,654.82 |
| Accounts Receivable |
3,549,003,312.57 |
| Advances to Suppliers |
2,444,427,685.47 |
| Other Receivables |
1,723,827,088.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
54,722,320.62 |
| Inventories |
4,863,716,289.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
278,733,833.26 |
| Total Current Assets |
15,957,944,735.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,038,092,448.73 |
| Investment Properties |
344,599,788.49 |
| Fixed Assetes |
1,437,555,689.45 |
| Under-construction Projects |
6,526,954.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
189,683,233.76 |
| R&D expenses |
-- |
| Goodwill |
354,461,345.56 |
| Long-Term Deferred and Prepaid Expenses |
195,209,092.92 |
| Deferred Income Tax Assets |
229,078,255.99 |
| Other Non-Current Assets |
7,265,031.06 |
| Sub-Total of Non-Current Assets |
4,390,109,699.14 |
| Total Assets |
20,348,054,434.19 |
| Short-Term Loans |
8,318,009,471.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,218,648,998.43 |
| Accounts Payable |
754,056,742.53 |
| Accounts Received In Advance |
747,132.05 |
| Employee Compensation Payable |
52,983,141.30 |
| Taxes Payable |
34,006,074.08 |
| Interest Payable |
-- |
| Dividend Payable |
4,838,107.74 |
| Other payables |
1,084,581,253.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,332,786,391.07 |
| Other Current Liabilities |
166,440,893.56 |
| Sub-Total of Current Liabilities |
15,259,395,009.47 |
| Long-term Loans |
1,019,680,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
107,406,729.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,106,319.81 |
| Deferred Income Tax Liabilities |
62,793,257.31 |
| Other Non-Current Liabilities |
30,933,577.34 |
| Sub-Total of Non-Current Liabilities |
1,494,562,026.53 |
| Total Liabilities |
16,753,957,036.00 |
| Paid-In Capital(Or Share Stock) |
565,008,376.00 |
| Capital Surplus |
2,244,676,276.72 |
| Surplus Reserve |
120,141,440.57 |
| LESS:Treasury Stock |
102,749,040.00 |
| Undistributed Profits |
-2,387,602,869.94 |
| Minority Stockholder's Interest |
1,114,292,060.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,479,805,337.81 |
| Owner's Equity（Stockholder's Equity） |
3,594,097,398.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,348,054,434.19 |
